 "pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing")
The Drugs Technical Advisory Board (DTAB) is likely to meet on Monday to decide the fate of 19 fixed-dose combinations (FDCs) drugs that are considered 'irrational combinations'.
Some of the common medicine brands which are under the scanner include cough syrup Ascoril C, TeddyKoff, and some cold medicines like D'Cold Total, Dolo Cold, headache medicines like Saridon etc.
The drugmakers have been asked to generate additional data on these drugs through phase-4 trials (trials done after marketing approval). The Drugs Controller General of India (DCGI) feels that additional data is required for these drugs, and thus pharma companies have been
